Home >> Industry News >> Qiagen, DiaSorin receive FDA approval for Liaison QFT-Plus

Qiagen, DiaSorin receive FDA approval for Liaison QFT-Plus

image_pdfCreate PDF

The Liaison’s workflow for QFT-Plus was introduced in Europe in 2018 and is planned for China in 2020. Additional tests based on QuantiFeron technology are planned for adaptation to the Liaison platforms.

CAP TODAY
X